The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Given Imaging missed estimates on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue was unchanged and GAAP earnings per share contracted.
Margins contracted across the board.
Given Imaging reported revenue of $48.7 million. The two analysts polled by S&P Capital IQ hoped for revenue of $52.9 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.25. The two earnings estimates compiled by S&P Capital IQ forecast $0.30 per share. GAAP EPS of $0.16 for Q4 were 11% lower than the prior-year quarter's $0.18 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 74.6%, 280 basis points worse than the prior-year quarter. Operating margin was 7.5%, 350 basis points worse than the prior-year quarter. Net margin was 10.5%, 110 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $48.2 million. On the bottom line, the average EPS estimate is $0.20.
Next year's average estimate for revenue is $205.8 million. The average EPS estimate is $0.95.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 119 members out of 134 rating the stock outperform, and 15 members rating it underperform. Among 26 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 24 give Given Imaging a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Given Imaging is outperform, with an average price target of $22.00.
Is Given Imaging the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Given Imaging to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
3 Next-Generation Trends in Medical Tech You Need to Know
From new takes on old technologies to cutting-edge innovations such as robotic surgery and bioprinting, these trends are revolutionizing the future of med tech.
Given Imaging Ltd. Gets FDA Clearance for Colonoscopy Pill Camera
Before the completion of the acquisition by Covidien, Given Imaging announced its PillCam COLON camera had been approved by the FDA for use in patients with incomplete colonoscopies.
Is This the Best Health Care Acquisition of 2013?
Covidien's purchase of imaging device maker Given Imaging might have come at a steep price, but it offers innovative potential for the long run for this company.